Western drugs largely continue to be supplied to Russia

February 7, 2023

The Russian pharmaceutical market has generally withstood the pressure of sanctions from West, as foreign companies stopped supplying only 8% of drug names to Russia, reports The Pharma Letter’s local correspondent.

According to latest data published by the Russian analytics company RNC Pharma, only 99 drugs were no longer imported into Russia in 2022. This is approximately 8% of all drug names delivered to the local market last year. Among them, in particular, are the anti-Parkinsonian drug levodopa + benzerazide, the antitumor therapy toremifene and obinutuzumab, as well as the analgesic ibuprofen + codeine (known under the brand name Nurofen Plus).